FDA Approves First-Ever Topical Gene Therapy

Brasil Notícia Notícia

FDA Approves First-Ever Topical Gene Therapy
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Medscape
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 55%

FDA OKs first-ever topical gene therapy, for rare skin disease

"Vyjuvek is the first FDA-approved gene therapy treatment for DEB, a rare and serious genetic skin disorder," said Peter Marks, MD, PhD, director of the FDA's Center for Biologics Evaluation and Research,"With the FDA approval of Vyjuvek, the DEB population has reached a monumental milestone in the treatment of this horrible disorder," said Brett Kopelan, executive director of debra of America, a national advocacy group for people with...

"Because it's safe and easy to apply directly to wounds, it doesn't require a lot of supporting technology or specialized expertise, making Vyjuvek highly accessible even to patients who live far away from specialized centers," he said. Kopelan, the patient advocate, said that his organization"will continue to work closely with Krystal to assure patients have ready access to Vyjuvek."affects 1 to 3 people per million in the United States. It is caused by mutations in thegene, which encodes the alpha-1 chain of collagen type VII protein. C7 forms the anchoring fibrils that attach the epidermis to the underlying dermal connective tissue.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Medscape /  🏆 386. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Murray proposes that insurers fully cover over-the-counter birth control if FDA approvesMurray proposes that insurers fully cover over-the-counter birth control if FDA approvesThe senator says getting birth control onto the shelves of your local pharmacy is a priority.
Consulte Mais informação »

FDA Approves Upadacitinib (Rinvoq) for Crohn's DiseaseFDA Approves Upadacitinib (Rinvoq) for Crohn's DiseaseFDAapproves JAK inhibitor upadacitinib for adults with moderately to severely active Crohns disease whose condition failed to respond adequately or who can't tolerate one or more TNF inhibitors.
Consulte Mais informação »

U.S. FDA approves Genmab-AbbVie's blood cancer therapyU.S. FDA approves Genmab-AbbVie's blood cancer therapyThe U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker Genmab's blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said on Friday.
Consulte Mais informação »

FDA panel recommends the first shot to prevent RSV in infants by vaccinating pregnant mothersFDA panel recommends the first shot to prevent RSV in infants by vaccinating pregnant mothersBREAKING: FDA panel recommends first shot to prevent RSV in infants by vaccinating pregnant mothers. If the shot gets approved, it would be the first RSV vaccine that confers protection to babies.
Consulte Mais informação »

First RSV vaccine to protect infants wins backing of FDA panelFirst RSV vaccine to protect infants wins backing of FDA panelThe first vaccine to protect babies from the respiratory virus RSV is a step closer to approval, after a panel of the Food and Drug Administration's outside vaccine advisers voted to back the safety and effectiveness of a new shot developed by Pfizer.
Consulte Mais informação »

First-ever Pixel 8 Pro hands-on video reveals a surprising new featureFirst-ever Pixel 8 Pro hands-on video reveals a surprising new featureGoogle's upcoming Pixel 8 Pro is today starring in its first leaked hands-on video, revealing that a thermometer resides on its back next to the triple camera system and LED flash.
Consulte Mais informação »



Render Time: 2025-02-26 18:36:52